Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Hyperoxaluria

Not recruiting

Registered drugNo placebo

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Lumasiran

Contact Research Centre

Endometrial cancer+4

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Anhydrous Caffeine

Contact Research Centre

Factor IX deficiency

Not recruiting

InvestigationalNo placebo

Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

InvestigationalNo placebo

Belgium

Participants:18–64 years
Substances:Fidanacogene Elaparvovec

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Ovarian epithelial cancer

Not recruiting

Registered drug

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Cholangitis sclerosing

Not recruiting

Investigational

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Volixibat

Contact Research Centre

Find therapies in clinical trials near you – page 51

637 trials match your criteria

Fallopian tube cancer+1

Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Hidradenitis

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Hormone receptor positive HER2 negative breast cancer

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Hyperoxaluria

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Endometrial cancer+4

Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

Factor IX deficiency

Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

Breast cancer+2

Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Ovarian epithelial cancer

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Cholangitis sclerosing

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.